Exome sequencing of germline DNA from non-BRCA1/2 familial breast cancer cases selected on the basis of aCGH tumor profiling.

Exome sequencing of germline DNA from non-BRCA1/2 familial breast cancer cases selected on the basis of aCGH tumor profiling.

The bulk of familial breast cancer risk (∼70%) cannot be explained by mutations in the known predisposition genes, primarily BRCA1 and BRCA2. Underlying genetic heterogeneity in these cases is the probable explanation for the failure of all attempts to identify further high-risk alleles. While exome...

Full description

Bibliographic Details
Main Authors: Florentine S Hilbers, Caro M Meijers, Jeroen F J Laros, Michiel van Galen, Nicoline Hoogerbrugge, Hans F A Vasen, Petra M Nederlof, Juul T Wijnen, Christi J van Asperen, Peter Devilee
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23383274/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23383274/?tool=EBI

Similar Items